Literature DB >> 10099860

Indirect costs of migraine in a managed care population.

P Fishman1, L Black.   

Abstract

Migraine is a highly prevalent condition that commonly affects individuals during their most productive years. The aggregate cost of providing healthcare for persons with migraine is substantial, but the economic consequences of lost and reduced productivity among this population are greater. This paper presents estimates of the annual indirect costs associated with migraine in a managed-care population. Our estimates include workplace and domestic productivity losses for persons employed outside the home as well as those persons engaged exclusively in domestic production or who are unable to work. We find that migraine is associated with annual indirect costs for men and women, respectively, of $4,548 and $4,897 in 1990 dollars, and that indirect costs increase with headache severity. Further research should continue to emphasize headache's effect on domestic production in order to avoid bias in measuring the economic effect of headache on women.

Entities:  

Mesh:

Year:  1999        PMID: 10099860     DOI: 10.1111/j.1468-2982.1999.1901050.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  7 in total

Review 1.  The impact of migraine and the effect of migraine treatment on workplace productivity in the United States and suggestions for future research.

Authors:  Wayne N Burton; Stephen H Landy; Kristen E Downs; M Chris Runken
Journal:  Mayo Clin Proc       Date:  2009-05       Impact factor: 7.616

Review 2.  Workplace productivity. A review of the impact of migraine and its treatment.

Authors:  P Stang; R Cady; A Batenhorst; L Hoffman
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 3.  Migraine is a neuronal disease.

Authors:  J Tajti; A Párdutz; E Vámos; B Tuka; A Kuris; Zs Bohár; A Fejes; J Toldi; L Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2010-12-15       Impact factor: 3.575

4.  The burden of migraine in Spain: beyond direct costs.

Authors:  Xavier Badia; Sol Magaz; Laura Gutiérrez; Jordi Galván
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

5.  Antimigraine medication use and associated health care costs in employed patients.

Authors:  Jun Wu; Mary D Hughes; Matthew F Hudson; Peggy J Wagner
Journal:  J Headache Pain       Date:  2011-11-30       Impact factor: 7.277

6.  Experiences and perceptions of people with headache: a qualitative study.

Authors:  Deborah A Leiper; Alison M Elliott; Philip C Hannaford
Journal:  BMC Fam Pract       Date:  2006-05-02       Impact factor: 2.497

7.  Productivity Losses Due to Migraine in Slovenia: An Analysis of Absenteeism and Presenteeism Costs Based on Administrative and Self-Reported Data.

Authors:  Aleša Lotrič Dolinar; Bojana Žvan; Petra Došenović Bonča
Journal:  Zdr Varst       Date:  2020-04-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.